Alkermes ALKS
NASDAQ ALKS
$48.73 -1.45 (-2.89%)
At close: Aug 20, 2026 · 12:56 PM UTC

Alkermes (ALKS) Return on Invested Capital (QoQ) (2012 - 2025)

Alkermes (ALKS) Return on Invested Capital (QoQ) (2012 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.96 Bn 43.00 Bn -
2 Teva Pharmaceutical Industries 43.23 Bn 39.58 Bn 2.15 Bn
3 Zoetis 31.76 Bn 30.08 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn
6 Viatris 18.69 Bn 17.81 Bn 1.46 Bn
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn
8 Elanco Animal Health 11.78 Bn 11.25 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn -
10 Alkermes 8.14 Bn 7.48 Bn 397.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2025 27.00
Mar 31, 2025 10.00
Dec 31, 2024 3.00
Sep 30, 2024 0.00
Jun 30, 2024 -16.00
Mar 31, 2024 4.00
Dec 31, 2023 6.00
Sep 30, 2023 12.00
Jun 30, 2023 31.00
Mar 31, 2023 -5.00
Dec 31, 2022 -1.00
Sep 30, 2022 -5.00
Jun 30, 2022 -2.00
Mar 31, 2022 0.00
Dec 31, 2021 13.00
Sep 30, 2021 0.00
Jun 30, 2021 4.00
Mar 31, 2021 2.00
Dec 31, 2020 -4.00
Sep 30, 2020 4.00